Sorry, I was processed by the evil spirit of an adult film chargers scammer...
GO BCAP.
RELEASE THE NEWS MATT, RELEASE THE NEW!
An earnings release already turns the market into a bar fight; 24X wants to put part of that fight inside a regulated binary-options contract. The Stamford-based exchange has filed a proposed rule change with the SEC for 24X Options, a facility that would offer a conventional options market alongside contracts tied to company performance targets. It is an interesting...
Continue Reading
Japan's crypto gatekeepers just handed Mantle a key, not a crown. The November 18 listing of $MNT on GMO Coin is a meaningful operational win because getting onto a Japanese centralized exchange is not the usual loose-change exercise seen in friendlier jurisdictions. Mantle cleared a review process involving GMO Coin and the Japan Virtual and Crypto Assets Exchange...
Continue Reading
Brain-tumor progress rarely arrives with a clean victory lap, but the longer INDIGO readout gives clinicians and sector watchers something sturdier than a one-time headline. Servier presented extended Phase 3 results for VORANIGO, or vorasidenib, at the Society for Neuro-Oncology meeting in Philadelphia on November 14 and 15, 2026. The central message is durable benefit...
Continue Reading
Private wealth is about to get squeezed from three directions at once: younger heirs, smarter machines and assets that do not fit neatly in the old family-office binder. That is the real backdrop to the Future of Wealth Forum, a new GFTN and Luxembourg House of Financial Technology partnership slated for Luxembourg City on September 27-29, 2027. It is early days,...
Continue Reading
A fund can vanish faster than investors can read the fine print, and TYYY is doing exactly that. Exchange Traded Concepts has approved the closure and liquidation of the xETFs TSLA Daily Income ETF, with the fund expected to cease operations and distribute cash on or about November 20, 2026. This is not a debate about whether holders should love or hate Tesla. The product...
Continue Reading
Eight years is long enough to separate a useful science partner from a glossy slide deck, and Vertex’s decision to add four more years with Genomics deserves attention. This is not a splashy acquisition, nor is it a clean revenue number investors can plug into next quarter’s model. It is a deeper commitment to the slow, expensive, wonderfully unforgiving business of...
Continue Reading
Airline discounts can look like generosity until the load factor starts talking back. Avelo Airlines has joined WeSalute with fare discounts for active-duty military members, veterans, first responders, nurses, medical professionals, public servants, teachers and eligible family members. It is a sensible move for a young carrier built around smaller airports and lower...
Continue Reading
Breathing trouble gets shrugged off far too easily, and that casual mistake has consequences. World COPD Day puts chronic obstructive pulmonary disease back in view, with the American Lung Association emphasizing a free Lung Health Navigator program for people living with COPD, their caregivers and families. This is not flashy medicine or a miracle-cure pitch. It is...
Continue Reading
An $8.25-per-share securities markdown is the splinter in an otherwise sturdy third-quarter report from Lake Ridge Bancorp. The bank earned $9.8 million, or $4.97 per common share, for the quarter ended September 30, 2026. That is up from $9.0 million, or $4.59 per share, in the prior quarter and $7.7 million, or $3.94 per share, a year earlier. Those are not flimsy...
Continue Reading
Pioneering Ventures in Japan's Space Race Watch out, folks—Auria and LSAS Tec have something cooking. One's a titan in space technology, and the other's a maestro in mission analysis. They're joining forces to tango in Japan's booming space market. If you're into the street-smart equity dance, this partnership ain't just chatter over coffee; it's a leap toward new...
Continue Reading
Dover Set to Release Q2 2025 Earnings Dover is gearing up to share its financial results for the second quarter of 2025, scheduled for release at approximately 6:00 a.m. Central time on the upcoming Thursday. This significant event marks a crucial moment for shareholders and analysts alike, as they anticipate insights into the company's performance and strategic moves....
Continue Reading
Investigation of ImmunityBio, Inc. In recent developments, Bragar Eagel & Squire, P.C., a well-respected law firm specializing in shareholder rights, has launched an investigation regarding ImmunityBio, Inc. (NASDAQ: IBRX). This probe is geared towards looking into potential legal claims on behalf of long-term shareholders, aiming to ensure their interests are safeguarded...
Continue Reading
Norges Bank's Recent Notification Regarding Stake in Syensqo Norges Bank has recently communicated a significant change regarding its participation in Syensqo. This notification, in line with Belgian transparency laws, reveals that Norges Bank has crossed the 3% voting rights threshold, which is vital for all stakeholders. Understanding the Changes in Voting Rights The...
Continue Reading
Key Developments in ZyVersa's Clinical Journey Important Highlights: Announcement of a Phase 2a proof-of-concept clinical trial for Cholesterol Efflux Mediator™ VAR 200 focusing on patients with diabetic kidney disease planned for the first half of 2025. The regulatory framework for VAR 200’s primary indication, focal segmental glomerulosclerosis (FSGS), is set to...
Continue Reading
Overview of the Bunion Surgery Market The global Bunion Surgery Market is witnessing substantial growth, projected to increase from US$437.8 million in 2023 to an impressive US$606.1 million by 2029, achieving a CAGR of 5.7%. The surge in demand for surgical treatments primarily arises from the rising incidence of bunions, particularly among the aging population who are...
Continue Reading